<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13D-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(AMENDMENT NO. ___)(1)
UNITED THERAPEUTICS CORPORATION
(Name of Issuer)
COMMON STOCK, $ .01 PAR VALUE
(Title of Class of Securities)
91307C102
-----------------------------
(CUSIP Number)
CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE
IS FILED:
[ ] RULE 13d-1(b)
[ ] RULE 13d-1(c)
[X] RULE 13d-1(d)
- - - - -------------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
- - - - --------------------------------------------------------------------------------
CUSIP NO. 91307C102 13G PAGE 2 OF 4 PAGES
----- -----
- - - - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Noah A. Samara
- - - - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
- - - - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - - - --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- - - - --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER
2,385,229
OF SHARES -----------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
None
OWNED BY -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
2,385,229
REPORTING -----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON WITH
None
- - - - --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,385,229
- - - - --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- - - - --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.9%
- - - - --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- - - - --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- - - - --------------------------------------------------------------------------------
<PAGE> 3
ITEM 1(a). NAME OF ISSUER:
United Therapeutics Corporation
ITEM 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
1110 Spring Street
Silver Spring, MD 20910
ITEM 2(a) NAME OF PERSON FILING:
Noah A. Samara
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
2400 N Street, N.W.
Washington, DC 20037
ITEM 2(c) CITIZENSHIP:
United States of America
ITEM 2(d) TITLE OF CLASS OF SECURITIES:
Common Stock, $.01 par value
ITEM 2(e) CUSIP NUMBER:
91307C102
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b)
OR (c), CHECK WHETHER THE PERSON FILING IS A:
Not applicable
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified
in Item 1.
(a) AMOUNT BENEFICIALLY OWNED:
2,385,229
(b) PERCENT OF CLASS:
12.9%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR TO DIRECT THE VOTE
2,385,229
(ii) SHARED POWER TO VOTE OR TO DIRECT THE VOTE
None
<PAGE> 4
(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF
2,385,229
(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF
None
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATIONS.
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.
February 14, 2000
---------------------------------
(Date)
/s/ Noah A. Samara
---------------------------------
(Signature)
Noah A. Samara
---------------------------------
(Name/Title)
